Cargando…
United States Pharmacopeia (USP) Safety Review of Gamma-Aminobutyric Acid (GABA)
Gamma-amino butyric acid (GABA) is marketed in the U.S. as a dietary supplement. USP conducted a comprehensive safety evaluation of GABA by assessing clinical studies, adverse event information, and toxicology data. Clinical studies investigated the effect of pure GABA as a dietary supplement or as...
Autores principales: | Oketch-Rabah, Hellen A., Madden, Emily F., Roe, Amy L., Betz, Joseph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399837/ https://www.ncbi.nlm.nih.gov/pubmed/34444905 http://dx.doi.org/10.3390/nu13082742 |
Ejemplares similares
-
United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts
por: Oketch-Rabah, Hellen A., et al.
Publicado: (2020) -
Considerations for determining safety of probiotics: A USP perspective
por: Roe, Amy L., et al.
Publicado: (2022) -
Understanding of pictograms from the United States Pharmacopeia Dispensing Information (USP-DI) among elderly Brazilians
por: Barros, Izadora MC, et al.
Publicado: (2014) -
The New Pharmacopeia
Publicado: (1905) -
The New Pharmacopeia
por: Daniel, R. P.
Publicado: (1905)